Population pharmacokinetics (PK) pharmacodynamics (PD) of minoxidil (MNX).

被引：0
|
作者：
Fadiran, EO
Miller, R
Ludden, T
Karkowsky, A
Parekh, A
Ferry, J
机构：
[1] US FDA, ROCKVILLE, MD 20857 USA
[2] UNIV NEBRASKA, MED CTR, DEPT PHARM SCI, OMAHA, NE 68198 USA
[3] UPJOHN CO, UPJOHN LABS, KALAMAZOO, MI 49001 USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 1997年 / 61卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
下载
收藏
页码：PII46 / PII46
页数：1
相关论文
共 50 条
  • [21] Pharmacokinetics and pharmacodynamics (PK/PD) of terazosin in hypertensive patients.
    Granneman, R
    Achari, R
    Hosmane, B
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1996, 59 (02) : PII60 - PII60
  • [22] Pharmacokinetics (PK) and pharmacodynamics (PD) of lanoteplase in healthy subjects.
    Vachharajani, N
    Shyu, W
    Stouffer, B
    Raymond, R
    Liao, W
    Tay, L
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 65 (02) : 180 - 180
  • [23] Ketoprofen in piglets: enantioselective pharmacokinetics, pharmacodynamics and PK/PD modelling
    Fosse, T. K.
    Toutain, P. L.
    Spadavecchia, C.
    Haga, H. A.
    Horsberg, T. E.
    Ranheim, B.
    JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2011, 34 (04) : 338 - 349
  • [24] CODEINE PHARMACOKINETICS (PK) AND PHARMACODYNAMICS (PD) IN HEMODIALYSIS (HD) PATIENTS
    GUAY, DRP
    MATZKE, GR
    FINDLAY, JWA
    HALSTENSON, CE
    AWNI, WM
    OPSAHL, JA
    ABRAHAM, PA
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1987, 41 (02) : 222 - 222
  • [25] Editorial: Pharmacokinetics, pharmacodynamics (PK/PD) of antibiotics: A reality check
    Zeitlinger, Markus
    Tillotson, Glenn
    Echols, Roger
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [26] PHARMACOKINETICS (PK) AND PHARMACODYNAMICS (PD) OF TORSEMIDE IN CIRRHOSIS-(C)
    RUDY, D
    SCHWARTZ, S
    BRATER, DC
    POUND, D
    GREENE, P
    KRAMER, W
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1993, 53 (02) : 235 - 235
  • [27] Effects of Canagliflozin on the Pharmacokinetics (PK) and Pharmacodynamics (PD) of Metformin and Glyburide
    Devineni, Damayanthi
    Sarich, Troy C.
    Wexler, David
    Shalayda, Kevin
    Ghosh, Atalanta
    Skee, Donna
    Rothenberg, Paul L.
    Usiskin, Keith
    DIABETES, 2011, 60 : A604 - A604
  • [28] Safety, pharmacokinetics (PK), and pharmacodynamics (PD) of WAY-195725.
    Zhou, H
    Diehl, A
    Waldman, S
    Shen, M
    Clark, J
    Raible, D
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (02) : P51 - P51
  • [29] PHARMACOKINETICS AND PHARMACODYNAMICS OF KETOPROFEN IN CALVES APPLYING PK/PD MODELING
    LANDONI, MF
    CUNNINGHAM, FM
    LEES, P
    JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 1995, 18 (05) : 315 - 324
  • [30] The pharmacodynamics (PD) and pharmacokinetics (PK) of coadministration of omapatrilat (OMA) and atenolol (AT).
    Hammett, J
    Hutman, HW
    Malhotra, B
    Ferreira, I
    Slugg, P
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 67 (02) : 124 - 124
12345